Our findings imply that DHRS2-mediated p53 accumulation does not occur in p53-mutant Jurkat cells and overexpression of LEF1 may show oncogenic effects via overexpression of its downstream target, MYC, which is known to play a major role in T-ALL [6,47]. The gene discussed is DHRS2; the disease is acute lymphoblastic leukemia.